Cargando…

Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial

PURPOSE: To evaluate the efficacy and safety of re-treatment with anticholinergics on refractory idiopathic overactive bladder (OAB) previously treated with intravesical botulinum neurotoxin type A (BTX-A) injections. METHODS: One hundred patients were initially managed by intravesical injections of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elbaset, M.A., Taha, Diaa-Eldin, El-Hefnawy, Ahmed S., Zahran, Mohamad H., Shokeir, A.A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Continence Society 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790821/ https://www.ncbi.nlm.nih.gov/pubmed/31607104 http://dx.doi.org/10.5213/inj.1938098.049

Ejemplares similares

Validation of the Arabic linguistic version of the Overactive Bladder Symptoms Score questionnaire
por: Elbaset, M. A., et al.
Publicado: (2019)

Refractory overactive bladder: Beyond oral anticholinergic therapy
por: Glinski, Ronald W., et al.
Publicado: (2007)

Clinical Efficacy in the Treatment of Overactive Bladder Refractory to Anticholinergics by Posterior Tibial Nerve Stimulation
por: Arrabal-Polo, Miguel Angel, et al.
Publicado: (2012)

Delivery of intravesical botulinum toxin A using low-energy shockwaves in the treatment of overactive bladder: A preliminary clinical study
por: Nageib, Mohammed, et al.
Publicado: (2019)

Effect of Desmopressin with Anticholinergics in Female Patients with Overactive Bladder
por: Han, Young Kook, et al.
Publicado: (2011)

Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder
por: Araklitis, George, et al.
Publicado: (2020)

Selective embolisation for intractable bladder haemorrhages: A systematic review of the literature
por: Taha, Diaa-Eldin, et al.
Publicado: (2018)

The Impact of Gene Polymorphisms on the Success of Anticholinergic Treatment in Children with Overactive Bladder
por: Gurocak, Serhat, et al.
Publicado: (2015)

Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
por: Sartori, Luisa Gracio Ferreira, et al.
Publicado: (2023)

Anticholinergic Burden and Associated Healthcare Resource Utilization in Older Adults with Overactive Bladder
por: Jaggi, Ashley, et al.
Publicado: (2021)

Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics
por: Yehoshua, Alon, et al.
Publicado: (2016)

Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review
por: Dmochowski, Roger R., et al.
Publicado: (2023)

Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2014)

The satisfaction of patients with refractory idiopathic overactive bladder with onabotulinumtoxinA and augmentation cystoplasty
por: El-Azab, Ahmed S., et al.
Publicado: (2013)

Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity
por: Hui, C, et al.
Publicado: (2016)

The surgical management of the refractory overactive bladder
por: Vasdev, Nikhil, et al.
Publicado: (2010)

Erratum: Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2015)

Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder
por: Lozano-Ortega, Greta, et al.
Publicado: (2020)

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis
por: Sussman, D., et al.
Publicado: (2017)

Is there any Relationship Between Bladder Trabeculation and Efficacy and Safety of Intravesical Botulinum Toxin A Injection in Refractory Idiopathic Overactive Bladder Women?
por: Zargham, Mahtab, et al.
Publicado: (2017)

Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature
por: Taha, Diaa-Eldin, et al.
Publicado: (2018)

Refractory overactive bladder: a common problem?
por: Schwantes, Ulrich, et al.
Publicado: (2015)

AB206. Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity
por: Chen, Hui, et al.
Publicado: (2016)

Efficacy of intravaginal electrical stimulation with different treatment frequency in women with refractory idiopathic overactive bladder
por: Yildiz, Necmettin, et al.
Publicado: (2022)

After urgent drainage of an obstructed kidney by internal ureteric stenting; is ureteroscopic stone extraction always needed?
por: Taha, Diaa-Eldin, et al.
Publicado: (2015)

Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study
por: Just, Katja S., et al.
Publicado: (2023)

BTX modification of Na channels in squid axons. I. State dependence of BTX action
Publicado: (1991)

The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents
por: Masumori, Naoya, et al.
Publicado: (2011)

Temporary cognitive impairment related to administration of newly developed anticholinergic medicines for overactive bladder: two case reports
por: Shiota, Takako, et al.
Publicado: (2014)

Rationale for the Use of Anticholinergic Agents in Overactive Bladder With Regard to Central Nervous System and Cardiovascular System Side Effects
por: Çetinel, Bülent, et al.
Publicado: (2013)

The Impact of Anticholinergic Use for Overactive Bladder on Cognitive Changes in Adults with Normal Cognition, Mild Cognitive Impairment, or Dementia
por: Welk, Blayne, et al.
Publicado: (2022)

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
por: Sievert, K-D, et al.
Publicado: (2014)

Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience
por: Mohanty, N. K., et al.
Publicado: (2008)

Initial clinical experience with selective bladder denervation for refractory overactive bladder
por: Tu, Le Mai, et al.
Publicado: (2018)

Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study
por: Szabo, Shelagh M, et al.
Publicado: (2019)

Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder
por: Chatterjee, Satabdi, et al.
Publicado: (2021)

Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
por: Rutman, Matthew P., et al.
Publicado: (2021)

The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US
por: Chatterjee, Satabdi, et al.
Publicado: (2021)

Antibiotic therapy in patients with high prostate-specific antigen: Is it worth considering? A systematic review
por: Taha, Diaa-Eldin, et al.
Publicado: (2019)

Percutaneous Tibial Nerve Stimulation in the Treatment of Refractory Idiopathic Overactive Bladder Syndrome: A Retrospective Cohort Study
por: Frey, Janine Nicole, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1mnge43b82gr3t1s4mjgb6cpbl